Prevention and treatment of lethal murine endotoxemia by the novel immunomodulatory agent MFP-14

Antimicrob Agents Chemother. 2001 May;45(5):1591-4. doi: 10.1128/AAC.45.5.1591-1594.2001.

Abstract

Multifunctional protein 14 (MFP-14) is a ubiquitous protein that inhibits the production of tumor necrosis factor alpha (TNF-alpha) and gamma interferon (IFN-gamma), which are involved in the pathogenesis of sepsis. Here, lipopolysaccharide (LPS)-induced lethality in mice was markedly reduced by MFP-14. The treatment also lowered LPS-induced levels of TNF-alpha and IFN-gamma in the blood.

MeSH terms

  • Adjuvants, Immunologic / therapeutic use*
  • Animals
  • Disease Models, Animal
  • Endotoxemia / chemically induced
  • Endotoxemia / drug therapy
  • Endotoxemia / metabolism
  • Endotoxemia / prevention & control*
  • Female
  • Heat-Shock Proteins / therapeutic use*
  • Interferon-gamma / metabolism
  • Lipopolysaccharides
  • Mice
  • Mice, Inbred BALB C
  • Proteins*
  • Ribonucleases*
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Adjuvants, Immunologic
  • Heat-Shock Proteins
  • Lipopolysaccharides
  • MFP14 protein, mouse
  • Proteins
  • Tumor Necrosis Factor-alpha
  • Interferon-gamma
  • Ribonucleases